Inside information, profit warning: Solwers issues new outlook for 2026 and updates its assessment of compliance with the covenant

Solwers expects 2026 EBITA to remain positive but below its 2025 level, with revenue slightly below 2025. The company said visibility into business and earnings development had improved since it withdrew its previous 2026 outlook on 17 June 2026; the article provides no actual 2025 figures.

Analysis

The change in guidance reduces the near-term risk of an unbounded earnings miss, but it does not establish a recovery: management still expects both EBITA and revenue below 2025. For a project-based consultancy, the key transmission mechanism is likely utilization and pricing. If demand remains soft, lower workload can pressure margins faster than revenue, while a positive full-year EBITA may offer little protection against further estimate cuts if the second-half run rate weakens.

The market may initially reward restored visibility; the more important 1–3 month test is whether reported utilization, order intake/backlog and cash conversion support the outlook. The release excerpt does not provide 2025 EBITA, an absolute 2026 estimate, or segment-level detail, so the implied earnings decline and valuation are not assessable. Treat the outlook as company guidance, not independent evidence of demand stabilization.

Over 6–18 months, persistent revenue contraction could constrain investment and hiring and weaken the group’s ability to retain capacity, but that is conditional on the downturn continuing. Conversely, improved project demand could produce operating leverage and make the cautious outlook a low bar. The contrarian point is that restored visibility may be a sentiment catalyst without being an earnings catalyst; avoid extrapolating a relief move into a turnaround thesis.

Key Decisions for Investors

• No forced directional trade on this excerpt alone. Before sizing SOLWERS, obtain the complete release and verify 2025 EBITA, the absolute 2026 outlook, order intake/backlog, utilization, and operating cash flow; these determine whether the implied decline is already reflected in the shares.
• If SOLWERS rallies materially on the restored outlook, consider fading the move rather than initiating a short immediately: the stated revenue and EBITA direction remains negative versus 2025, but valuation, liquidity and consensus expectations are unavailable. Keep risk defined and reassess against subsequent results.
• For the next 1–3 months, turn constructive only if reported order intake/backlog and utilization stabilize and management maintains the outlook; a downward revision, weaker cash conversion, or further deterioration in workload would invalidate the stabilization case.
• Monitor the next earnings release for EBITA trajectory and cash conversion, not just full-year guidance. Stronger-than-expected operating indicators would falsify the relief-rally-fade thesis; missed guidance or weaker demand would strengthen it.